LifeMD, Inc.
LFMDP- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0000948320
No open-market purchases or sales by LifeMD, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesLFMD
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding LFMDP, Q2 2026
No superinvestor reported holding LFMDP at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by LifeMD, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 11, 2025 (view filing) | Dec 9 | 2 days | Friedeman JessicaChief Marketing Officer | SSale | −15.0K | $3.61 | −$54.1K | −6.8%205.0K after | |
| Sep 12, 2025 (view filing) | Sep 10 | 2 days | Alvarez Nicholas PChief Acquisition Officer | SSale | −75.0K | $5.92 | −$444.0K | −11.0%605.0K after | |
| Aug 5, 2025 (view filing) | Jul 1 | 35 daysLate | Schreiber JustinChairman and CEO | SSale | −25.0K | $9.99 | −$249.8K | −1.0%2.48M after | 10b5-1 |
| Jul 3, 2025 (view filing) | Jul 1 | 2 days | Schreiber JustinChairman and CEO | SSale | −25.0K | $13.38 | −$334.5K | −1.0%2.50M after | 10b5-1 |
| Jun 18, 2025 (view filing) | Jun 16-17 | 2 days | Benathen Marc DavidChief Financial Officer | SSale | −125.0K | $13.46 | −$1.68M | −26.9%339.6K after | 2 lots10b5-1 |
| Jun 17, 2025 (view filing) | Jun 13 | 4 days | Yecies Eric HaroldChief Legal Officer & GC | SSale | −15.0K | $12.25 | −$183.8K | −48.2%16.1K after | |
| Jun 17, 2025 (view filing) | Jun 13 | 4 days | Galluppi StefanChief Innovation Officer | SSale | −85.0K | $12.38 | −$1.05M | −51.4%80.4K after | 10b5-1 |
| Jun 4, 2025 (view filing) | Jun 2 | 2 days | Schreiber JustinChairman and CEO | SSale | −25.0K | $12.47 | −$311.8K | −1.0%2.53M after | 10b5-1 |
| May 5, 2025 (view filing) | May 1-2 | 4 days | Schreiber JustinChairman and CEO | SSale | −25.0K | $7.53 | −$188.2K | −1.0%2.55M after | 2 lots10b5-1 |
| May 1, 2025 (view filing) | Apr 29 | 2 days | Schreiber JustinChairman and CEO | SSale | −50.0K | $7.78 | −$389.0K | −1.9%2.58M after | 10b5-1 |
Top 10 13F holders, Q2 2026
The largest institutional positions in LifeMD, Inc. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding LFMDP in 13F filings for Q2 2026.